4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity

European Journal of Immunology

Volumn 32, Issue 2, 2002, Pages 521-529

  Cooper, David ^a   Bansal Pakala, Pratima ^a   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

4 1BB; Clonal expansion; Costimulatory molecule; Cytotoxicity

Indexed keywords

ADJUVANT; CD137 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL DIVISION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTERFERON PRODUCTION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD137; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL SURVIVAL; CYTOTOXICITY, IMMUNOLOGIC; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0036175995     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200202)32:2<521::AID-IMMU521>3.0.CO;2-X     Document Type: Article

References (40)

1. CD28/B7 costimulation: A review
2. + cytotoxic T lymphocytes in the absence of exogenous help
3. + T cells in vitro
4. Role of 4-1BB in immune responses
5. T cell co-stimulatory molecules other than CD28
6. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor
7. Expression characteristics of two potential T cell mediator genes
8. Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4
9. Inducible T cell antigen 4-1BB. Analysis of expression and function
10. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies
11. Molecular and biological characterization of human 4-1BB and its ligand
12. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP
13. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand
14. 4-1BB T cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells
15. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling
16. - T lymphocytes by 4-1BB ligand
17. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
18. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand
19. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus
20. Monoclonal antibodies against the 4-1BB T cell activation molecule eradicate established tumors
21. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway
22. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine
23. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: Long- term remission of liver metastases in a mouse model
24. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
25. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination
26. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients
27. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion
28. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells
29. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death
30. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal
31. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of cd4 and cd8 T cells with similar efficacy
32. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation
33. CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen
34. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB
35. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B
36. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation
37. T cell receptor antagonist peptides induce positive selection
38. Generation, persistence, and modulation of Th0 effector cells: Role of autocrine IL-4 and IFN-γ
39. The JAM test. A simple assay for DNA fragmentation and cell death
40. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo